Enhancement of lipopolysaccharide-stimulated cyclooxygenase-2 mRNA expression and prostaglandin E2 production in gingival fibroblasts from individuals with Down syndrome-Reference-Cited by-同舟云学术

Enhancement of lipopolysaccharide-stimulated cyclooxygenase-2 mRNA expression and prostaglandin E2 production in gingival fibroblasts from individuals with Down syndrome

Published:2002-03 Issue:6 Volume:123 Page:663-674
ISSN:0047-6374
Container-title:Mechanisms of Ageing and Development
language:en
Short-container-title:Mechanisms of Ageing and Development

Author:

Otsuka Yoko,Ito Masayuki,Yamaguchi Masaru,Saito Shigeno,Uesu Kagumi,Kasai Kazutaka,Abiko Yoshimitsu,Mega Junichi

Publisher

Elsevier BV

Subject

Developmental Biology,Ageing

Reference53 articles.

1. Phagocytic function in Down syndrome—I. Chemotaxis;Barkin;J. Ment. Defic. Res.,1980

2. Phagocytic function in Down syndrome—II. Bactericidal activity and phagocytosis;Barkin;J. Ment. Defic. Res.,1980

3. Actinobacillus actinomycetemcomitans, Capnocytophaga and Porphyromonas gingivalis in subgingival plaque of adolescents with Down's syndrome;Barr-Agholme;Oral Microbiol. Immunol.,1992

4. Prostaglandin E2 level in gingival crevicular fluid from patients with Down syndrome;Barr-Agholme;Acta Odontol. Scand.,1997

5. Periodontal conditions and salivary immunoglobulins in individuals with Down syndrome;Barr-Agholme;J. Periodontol.,1998

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imbalance of IL-1 Family mRNA Expression and IL-37 as a Potential Therapeutic Target for Periodontal Inflammation in Down Syndrome;International Journal of Oral-Medical Sciences;2023-04-10

2. Trisomy 21 impairs PGE2 production in dermal fibroblasts;PROSTAG OTH LIPID M;2021

3. Trisomy 21 impairs PGE2 production in dermal fibroblasts;Prostaglandins & Other Lipid Mediators;2021-04

4. Periodontal status of individuals with Down syndrome: sociodemographic, behavioural and family perception influence;Journal of Intellectual Disability Research;2019-05-07

5. Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model;2018-12-17